Discover 1,621 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,621
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Durham NC, Fairfax VA, New Brunswick NJ, Cleveland OH,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase1, Recruiting
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
for
Solid Tumors
Location: Durham NC, Spartanburg SC, Fairfax VA,
Sponsor: ORIC Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05315700
Phase1, Phase2, Recruiting
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
for
Low-grade Glioma, Advanced Solid Tumor
Location: Durham NC, Washington DC, Philadelphia PA, New York NY,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 0 - 25
Code: NCT04775485
Phase2, Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Durham NC, Roanoke VA, Norfolk VA, Fredericksburg VA,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase3, Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Durham NC, Chapel Hill NC, Cary NC, Roanoke VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase3, Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
for
Breast Cancer, Breast Cancer Metastatic,
Location: Durham NC, Charlotte NC, Augusta GA, Atlanta GA,
Sponsor: Incyclix Bio
Sex: All
Age: 18+
Code: NCT05735080
Phase1, Phase2, Recruiting
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
for
Extensive-Stage Small Cell Lung Cancer
Location: Durham NC, Roanoke VA, Marietta GA, Cincinnati OH,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06646276
Phase3, Recruiting
New
A Randomized Controlled Trial Testing a Digital, Gamified Early Intervention for Eating Disorders ("FlexED")
for
Eating Disorders, Body Image
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 15 - 25
Code: NCT07632248
Recruiting
New
Building Relationship, Improving Dialogue, and Growing Empathy (BRIDGE): An Intervention to Support Decision Making for Critically Ill Children
for
Decision Making, Neonatal Critical Illness,
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 0+
Code: NCT07390773
Recruiting
Registry of Arthrex Hand and Wrist Products
for
Ulnar/Radial Collateral Ligament Reconstruction,
Location: Durham NC, Morgantown WV, Tuscon AZ, Phoenix AZ
Sponsor: Arthrex, Inc.
Sex: All
Age: 18+
Code: NCT05046600
Recruiting
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
for
Lung Transplant
Location: Durham NC, Baltimore MD, Philadelphia PA, Cincinnati OH,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 12+
Code: NCT06476132
Phase2, Recruiting
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
for
Glioblastoma Multiforme
Location: Durham NC, Los Angeles CA, Santa Monica CA,
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT05708352
Phase2, Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
for
Neuroblastoma
Location: Durham NC, Charlotte NC, Richmond VA, Charleston SC,